Standardized Methods for Detection of Poliovirus Antibodies
- PMID: 26983734
- DOI: 10.1007/978-1-4939-3292-4_8
Standardized Methods for Detection of Poliovirus Antibodies
Abstract
Testing for neutralizing antibodies against polioviruses has been an established gold standard for assessing individual protection from disease, population immunity, vaccine efficacy studies, and other vaccine clinical trials. Detecting poliovirus specific IgM and IgA in sera and mucosal specimens has been proposed for evaluating the status of population mucosal immunity. More recently, there has been a renewed interest in using dried blood spot cards as a medium for sample collection to enhance surveillance of poliovirus immunity. Here, we describe the modified poliovirus microneutralization assay, poliovirus capture IgM and IgA ELISA assays, and dried blood spot polio serology procedures for the detection of antibodies against poliovirus serotypes 1, 2, and 3.
Keywords: Antibodies; Dried blood spot; ELISA; IPV; IgA; IgM; Neutralization; OPV; Poliovirus.
Similar articles
-
Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus.PLoS One. 2016 Jan 5;11(1):e0146010. doi: 10.1371/journal.pone.0146010. eCollection 2016. PLoS One. 2016. PMID: 26730586 Free PMC article. Clinical Trial.
-
Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.J Immunol. 1999 Apr 15;162(8):5011-8. J Immunol. 1999. PMID: 10202050
-
Immunoglobulin a as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population.Clin Infect Dis. 2002 Apr 15;34(8):1067-75. doi: 10.1086/339489. Epub 2002 Mar 20. Clin Infect Dis. 2002. PMID: 11914995
-
Mucosal immunity to poliovirus.Mucosal Immunol. 2022 Jan;15(1):1-9. doi: 10.1038/s41385-021-00428-0. Epub 2021 Jul 8. Mucosal Immunol. 2022. PMID: 34239028 Free PMC article. Review.
-
Antibody titer to the poliovirus in blood and cerebrospinal fluid of patients with post-polio syndrome.Ann N Y Acad Sci. 1995 May 25;753:201-7. doi: 10.1111/j.1749-6632.1995.tb27546.x. Ann N Y Acad Sci. 1995. PMID: 7611629 Review. No abstract available.
Cited by
-
Assessing the mucosal intestinal and systemic humoral immunity of sequential schedules of inactivated poliovirus vaccine and bivalent oral poliovirus vaccine for essential immunization in Bangladesh: An open-label, randomized controlled trial.Vaccine. 2024 Sep 17;42(22):126216. doi: 10.1016/j.vaccine.2024.126216. Epub 2024 Aug 14. Vaccine. 2024. PMID: 39146859 Free PMC article. Clinical Trial.
-
Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine.BMC Infect Dis. 2024 May 28;24(1):535. doi: 10.1186/s12879-024-09389-8. BMC Infect Dis. 2024. PMID: 38807038 Free PMC article.
-
The Immunogenicity of Monovalent Oral Poliovirus Vaccine Type 1 (mOPV1) and Inactivated Poliovirus Vaccine (IPV) in the EPI Schedule of India.Vaccines (Basel). 2024 Apr 17;12(4):424. doi: 10.3390/vaccines12040424. Vaccines (Basel). 2024. PMID: 38675806 Free PMC article.
-
Exploring the path to polio eradication: insights from consecutive seroprevalence surveys among Pakistani children.Front Public Health. 2024 Mar 27;12:1384410. doi: 10.3389/fpubh.2024.1384410. eCollection 2024. Front Public Health. 2024. PMID: 38601488 Free PMC article.
-
Poliovirus-Neutralizing Antibody Seroprevalence and Vaccine Habits in a Vaccine-Derived Poliovirus Outbreak Region in the Democratic Republic of Congo in 2018: The Impact on the Global Eradication Initiative.Vaccines (Basel). 2024 Feb 27;12(3):246. doi: 10.3390/vaccines12030246. Vaccines (Basel). 2024. PMID: 38543880 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous